Atlas Trials

Bioavailability of KBP-5074 Tablet vs Capsule Formulations

Clinical trial NCT03340753 · COMPLETED

Trial details

NCT number
NCT03340753
Sponsor
KBP Biosciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2017-10-26
Primary completion
2017-11-22
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.